share_log

Merck & Co | 4: Statement of changes in beneficial ownership of securities-Director GLOCER THOMAS H

SEC ·  Jul 3 01:25

Summary by Futu AI

Thomas H. Glocer, a reporting person for Merck & Co., Inc. [MRK], has engaged in a transaction involving the company's common stock on 06/28/2024. Following the transaction, Glocer holds a total of 5,100 shares of Merck & Co. directly. The nature of the shares is direct ownership, indicating a personal investment in the company. The transaction details, including the number of shares transacted and the price per share, were not disclosed. This action reflects a change in Glocer's investment in the pharmaceutical giant, and it may be of interest to investors monitoring insider activity as an indicator of company performance and executive confidence.
Thomas H. Glocer, a reporting person for Merck & Co., Inc. [MRK], has engaged in a transaction involving the company's common stock on 06/28/2024. Following the transaction, Glocer holds a total of 5,100 shares of Merck & Co. directly. The nature of the shares is direct ownership, indicating a personal investment in the company. The transaction details, including the number of shares transacted and the price per share, were not disclosed. This action reflects a change in Glocer's investment in the pharmaceutical giant, and it may be of interest to investors monitoring insider activity as an indicator of company performance and executive confidence.

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.